Invesaro

Stocks Health care POCI

NASDAQ · Health care

Precision Optics Corporation, Inc. (POCI)

Precision Optics Corporation, Inc. reported revenue of $31.5M in fiscal 2026, up 65.2% from a year earlier. It posted a net loss of $3.6M. In fiscal 2026 capital spending exceeded operating cash flow by $2M. At June 30, 2026 it held $9.8M in cash against $1.3M of debt. Its latest periodic report to the SEC is the annual report (10-K) filed on September 28, 2026.

Free, no password. An email when POCI files with the SEC.

Price
$5.00
+2.31% on the day · November 9, 2026
52-week range $3.55 to $6.15
Market cap
$54.7M
Revenue (FY2026)
$31.5M
+65.2% year on year
Net margin
-11.5%

Key facts about Precision Optics Corporation, Inc.

Net worth
Precision Optics Corporation, Inc. has a market value (market cap) of $54.7M at the latest share price, and shareholders' equity of $20.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2026 revenue was $31.5M (+65.2% year on year), with a net loss of $3.6M.
Cash flow
In fiscal 2026 operations used $1.6M of cash.
Latest report
The latest periodic report (annual report, 10-K) was filed with the SEC on September 28, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Precision Optics Corporation, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Precision Optics Corporation, Inc. does

Precision Optics Corporation, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker POCI.

Revenue and profit by year

Revenue
FY19: $6.8M $6.8M FY19FY20: $9.9M $9.9M FY20FY21: $10.7M $10.7M FY21FY22: $15.7M $15.7M FY22FY23: $21M $21M FY23FY24: $19.1M $19.1M FY24FY25: $19.1M $19.1M FY25FY26: $31.5M $31.5M FY26
Net income
FY19: -$614.9K -$614.9K FY19FY20: -$1.4M -$1.4M FY20FY21: -$102.8K -$102.8K FY21FY22: -$928.4K -$928.4K FY22FY23: -$144.6K -$144.6K FY23FY24: -$3M -$3M FY24FY25: -$5.8M -$5.8M FY25FY26: -$3.6M -$3.6M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$31.5M-$3.5M-$3.6M-$0.43-$2M
2025$19.1M-$5.6M-$5.8M-$0.85-$3.6M
2024$19.1M-$2.7M-$3M-$0.49-$3M
2023$21M-$638.5K-$144.6K-$0.03-$97.9K
2022$15.7M-$1.5M-$928.4K-$0.18-$1M
2021$10.7M-$905.6K-$102.8K-$0.03-$29.4K

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 12, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 13, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where POCI ranks in Health care

Revenue$31.5M
#447 of 751 in Health care · Bottom 41%
Revenue growth+65.2%
#72 of 532 in Health care · Top 13%
Net margin-11.5%
#293 of 544 in Health care · Bottom 46%
Free cash flow margin-6.3%
#283 of 490 in Health care · Bottom 42%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Precision Optics Corporation, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 28, 2026
    Quarterly results8-KPrecision Optics reported record fiscal year 2026 revenue of $31.5 million and issued fiscal 2027 revenue guidance of $30 million to $33 million.
  2. September 28, 2026
    Annual report10-K · period to June 30, 2026Precision Optics Corporation reported a 65.2% increase in total revenue for fiscal year 2026, driven by higher systems manufacturing volume.Revenue rose 65% to $31.5M versus the prior year; diluted EPS -$0.43 versus -$0.85.
  3. May 14, 2026
  4. May 13, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 108% to $8.7M versus the same quarter last year; diluted EPS -$0.01 versus -$0.30.
  5. March 31, 2026
  6. March 30, 2026
  7. March 20, 2026
  8. February 17, 2026
    Quarterly report 10-Q · period to December 31, 2025Revenue rose 63% to $7.4M versus the same quarter last year; diluted EPS -$0.23 versus -$0.15.
  9. February 3, 2026
  10. February 2, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 6, 2026. Insider transactions on SEC

Insider trades

What the people running Precision Optics Corporation, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 5 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
September 30, 2026 Coll Wayne MChief Financial Officer Received as pay 1,412 $4.43 $6.3K Form 4
September 30, 2026 Coll Wayne MChief Financial Officer Received as pay 6,250 $4.43 $27.7K Form 4
September 21, 2026 Traut JosephChief Operating Officer Received as pay 6,742 - - Form 4
September 21, 2026 Coll Wayne MChief Financial Officer Received as pay 6,742 - - Form 4
September 21, 2026 Forkey Joseph NormanChief Executive Officer, Director Received as pay 6,742 - - Form 4
June 30, 2026 Coll Wayne MChief Financial Officer Received as pay 1,257 $4.97 $6.2K Form 4
March 31, 2026 Coll Wayne MChief Financial Officer Received as pay 1,568 $3.99 $6.2K Form 4
March 30, 2026 Forkey Joseph NormanChief Executive Officer, Director Bought 1,388 $3.60 $5K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns POCI

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Needham Investment Management L.L.C.13G, passive with 3 related filers 15.3% 1,670,550 May 14, 2026
Teller Richard E13G, passive with 1 related filers 5.45% 420,262 November 21, 2025
Brian L. Pessin13D, may seek influence with 2 related filers 5% 550,673 March 31, 2026

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 31 managers reported a position.

HolderSharesValueChange on quarter
Needham Investment Management LLC1,670,550$8.5M0
Nantahala Capital Management, LLC560,000$2.9M+280,000
MYDA Advisors LLC375,000$1.9M-25,000
Vanguard Capital Management LLC325,751$1.7M+131,626
WealthTrust Axiom LLC260,458$1.3M+6,350
Morgan Stanley179,694$916.4K+35,900
HighTower Advisors, LLC124,343$634.1K+27,778
Geode Capital Management, LLC66,137$337.4K+155
Renaissance Technologies LLC54,100$275.9Knew
Essex Investment Management Co LLC46,630$237.8Knew
Stonepine Capital Management, LLC46,390$236.6K-53,610
Citadel Advisors LLC41,735$212.8K+18,500
Vanguard Fiduciary Trust Co38,747$197.6K+9,406
BlackRock, Inc.27,084$138.1K+10,979
Mesirow Financial Investment Management, Inc.23,364$119.2K-23,364
Jane Street Group, LLC21,374$109Knew
XTX Topco Ltd16,215$82.7K+6,139
Northern Trust Corp14,633$74.6K-8,779
Legato Capital Management LLC11,005$56.1Knew
Mercer Global Advisors Inc10,000$51Knew

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

4 insiders reported holding 258,955 shares in total, about $1.3M at the last price.

HolderSharesAs of
Forkey Joseph NormanChief Executive Officer, Director 150,701 September 21, 2026
Traut JosephChief Operating Officer 48,408 September 21, 2026
Coll Wayne MChief Financial Officer 46,218 September 30, 2026
Miclot Andrew J.Director 13,628 March 12, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about POCI

What does Precision Optics Corporation, Inc. do?

Precision Optics Corporation, Inc. is a company in the Health care sector, listed on NASDAQ as POCI. Its shares trade on NASDAQ under the ticker POCI.

What is Precision Optics Corporation, Inc.'s net worth?

Precision Optics Corporation, Inc. has a market value (market cap) of $54.7M at the latest share price, and shareholders' equity of $20.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Precision Optics Corporation, Inc. profitable?

No. In fiscal 2026 it reported a net loss of $3.6M on revenue of $31.5M.

How much revenue does Precision Optics Corporation, Inc. make?

In fiscal 2026 Precision Optics Corporation, Inc. reported revenue of $31.5M. That is 65.2% more than a year earlier.

When did Precision Optics Corporation, Inc. last report?

Its most recent periodic report is the annual report (10-K) filed on September 28, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade (amended) from October 6, 2026.

When is Precision Optics Corporation, Inc.'s next earnings report?

Precision Optics Corporation, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare POCI with

Compare POCI with any company

Follow POCI

Get an email when Precision Optics Corporation, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when POCI files with the SEC.

Where the numbers come from

Financial figures are the values Precision Optics Corporation, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.